Blog Voices from the Frontlines
The ONLY thing protecting state medical cannabis programs from Attorney General Jeff Session’s Department of Justice (DOJ) raids and arrests is an amendment to the Commerce, Justice, Science and Related Agencies (CJS) budget that prohibits the DOJ from spending federal funds to prosecute anyone participating in a medical cannabis program as long as they are abiding by state laws.
Contact your Senator TODAY and ask them to ensure that protections for state medical cannabis programs are in the budget for fiscal year 2018.
By Ray Stern for the Phoenix New Times
"But this is not to say if you could smoke cannabis it will cure your brain cancer. What we know is that, in animal studies, for rats and mice, we can cure cancer with cannabis or cannabis combined with chemotherapy." - Jahan Marcu
Washington D.C. -- This morning, the Senate Committee on Appropriations voted 24-7 to include an amendment introduced by Senators Steve Daines (R-MT) and Jeff Merkley (D-OR) in the FY2018 Military Construction, Veterans Affairs Appropriations bill. The amendment allows military veterans to participate in state medical cannabis programs without fear of losing their military benefits or services and enables Department of Veterans Affairs health care providers to recommend medical cannabis in compliance with state medical cannabis laws.
If you missed our 2017 Unity Conference: Securing the Role of Medical Cannabis in Modern Medicine, we are excited to let you know of an opportunity to be able to watch all the presentations you missed. You can get 24/7 access to the Unity Conference right now -- streaming only on Green Flower!
For the past five years, Unity has equipped patients, physicians and citizens to be successful medical cannabis policy advocates on all levels, from grassroots to government. If you’re serious about seeing (and driving) real change in medical cannabis laws, ensuring access for patients and reforming regulation, you need to see the ASA Unity Conference.
Today the Massachusetts Supreme Judicial Court ruled that a woman fired for using medical cannabis can sue her employer under a state handicap discrimination statute. This represents a great victory not only for the medical cannabis patients in Massachusetts, but for patients everywhere who have faced discrimination for far too long.
Washington D.C. — A meeting scheduled by the President's Commission on Combating Drug Addiction and the Opioid Crisis for this afternoon has been postponed until July 31, 2017. This is the second time the Commission has moved a meeting or call about the opioid crisis. The Commission was also scheduled to issue an interim report on June 27, but this deadline came and went without any announcement from the Commission.
PFC Offers Free Services for Laboratories To Help Address Opioid Epidemic - Americans for Safe Access
PFC Offers Free Services for Laboratories To Help Address Opioid Epidemic
Across the nation, opioid-related deaths and fatalities are decreasing in states that have medical cannabis programs, but the benefits are limited due to a lack of accurately labeled and tested cannabis products. In an effort to to help increase the number of safe and standardized medical products Americans for Safe Access will begin offering free assessments and certification services for cannabis testing laboratories through their Patient Focused Certification (PFC) program.
To receive a free laboratory assessment, click here to apply.
International Laboratory Certification Program Offers Free Services for Laboratories To Help Address Opioid Epidemic - Americans for Safe Access
Free medical cannabis laboratory assessments offered in an effort to help decrease opioid use and associated fatalities.
Washington, DC – Across the nation, opioid-related deaths and fatalities are decreasing in states that have medical cannabis programs, but the benefits are limited due to a lack of accurately labeled and tested cannabis products. Patient Focused Certification (PFC), a project of Americans for Safe Access, announced today that it will begin offering free assessments and certification services for cannabis testing laboratories to help increase the number of safe and standardized medical products, in an effort to help combat the opioid epidemic.
Dose reduction may improve pain, function, and quality of life for patients prescribed long-term opioid therapy for chronic pain. Results of a systematic evidence review are published in Annals of Internal Medicine.
Approximately 10 million U.S. adults are prescribed long-term opioid therapy for chronic pain. This dramatic increase in opioid prescribing has been accompanied by increases in opioid overdose. Expert guidelines recommend reducing or discontinuing long-term opioid therapy when risks outweigh the benefits, but evidence on the effects of dose reduction on patient outcomes had not been systematically reviewed.
In the July 2017 Issue:
- Mexico President Approves Safe Access
- Greece Announces Medical Access
- Attorney General Asks Congress to End Patient Protections
- New Revision to Cannabis Law for California
- ASA Urges Administration to Fight Opiate Crisis with Cannabis
- PFC Launches Training with Univ. of Maryland
- PFC Webinars Offer Online Help for Businesses
- ASA Activist Profile: Frank Buress, Wisconsin
- National Action Alert: Urge Congress to Renew Patient Protections